• Rajasingham R, Govender NP, Jordan A, et al. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022;22:1748–1755. The most up-to-date estimate of HIV-associated cryptococcal disease burden.

Boulware DR, Rolfes MA, Rajasingham R, et al. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast. Emerg Infect Dis. 2014;20:45–53.

Article  PubMed  PubMed Central  Google Scholar 

•• Bahr NC, Skipper CP, Huppler-Hullsiek K, et al. Recurrence of symptoms following cryptococcal meningitis: characterizing a diagnostic conundrum with multiple etiologies. Clin Infect Dis. 2023;76:1080–1087. Large recent study charactizing those presenting with second episode cryptococcal meningitis symptoms.

Poplin V, Boulware DR, Bahr NC. Methods for rapid diagnosis of meningitis etiology in adults. Biomark Med. 2020;14:459–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ellis J, Cresswell FV, Rhein J, Ssebambulidde K, Boulware DR. Cryptococcal meningitis and tuberculous meningitis co-infection in HIV-infected Ugandan adults. Open Forum Infect Dis. 2018;5:ofy193.

Article  PubMed  PubMed Central  Google Scholar 

Ellis J, Bangdiwala AS, Cresswell FV, et al. The changing epidemiology of HIV-associated adult meningitis, Uganda 2015–2017. Open Forum Infect Dis. 2019;6:ofz419.

Article  PubMed  PubMed Central  Google Scholar 

Hommel B, Sturny-Leclère A, Volant S, et al. Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype. PLoS Pathog. 2019;15:e1007945.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jarvis JN, Lawrence DS, Meya DB, et al. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N Engl J Med. 2022;386:1109–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis. N Engl J Med. 2014;370:2487–98.

Article  PubMed  PubMed Central  Google Scholar 

Flynn AG, Meya DB, Hullsiek KH, et al. Evolving failures in the delivery of human immunodeficiency virus care: lessons from a Ugandan meningitis cohort 2006–2016. Open Forum Infect Dis. 2017;4:ofx077.

Article  PubMed  PubMed Central  Google Scholar 

Tugume L, Semitala FC, Owachi D, Kagimu E, Kamya MR, Meya DB. Clinical characteristics and morbidity among hospitalized adults with advanced HIV disease in Uganda during “test and treat” era. PLOS Glob Public Health. 2023;3:e0002457.

Article  PubMed  PubMed Central  Google Scholar 

Espié E, Pinoges L, Balkan S, et al. Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia. Trop Med Int Health. 2010;15:1375–81.

Article  PubMed  Google Scholar 

Han X, Liu H, Wang Y, et al. A nomogram for predicting paradoxical immune reconstitution inflammatory syndrome associated with cryptococcal meningitis among HIV-infected individuals in China. AIDS Res Ther. 2022;19:20.

Article  PubMed  PubMed Central  Google Scholar 

Musubire AK, Boulware DR, Meya DB, Rhein J. Diagnosis and management of cryptococcal relapse. J AIDS Clin Res. 2013;Suppl 3(3):S3–003. https://doi.org/10.4172/2155-6113.s3-003.

Haddow LJ, Moosa MY, Mosam A, Moodley P, Parboosing R, Easterbrook PJ. Incidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa. PLoS ONE. 2012;7:e40623.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Bonham S, Meya DB, Bohjanen PR, Boulware DR. Biomarkers of HIV immune reconstitution inflammatory syndrome. Biomark Med. 2008;2:349–61.

Article  CAS  PubMed  Google Scholar 

Boulware DR, Bonham SC, Meya DB, et al. Paucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndrome. J Infect Dis. 2010;202:962–70.

Article  CAS  PubMed  Google Scholar 

Bahr N, Boulware DR, Marais S, Scriven J, Wilkinson RJ, Meintjes G. Central nervous system immune reconstitution inflammatory syndrome. Curr Infect Dis Rep. 2013;15:583–93.

Article  PubMed  Google Scholar 

Chang CC, Dorasamy AA, Gosnell BI, et al. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome. AIDS. 2013;27:2089–99.

Article  CAS  PubMed  Google Scholar 

Boulware DR, Meya DB, Bergemann TL, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7:e1000384.

Article  PubMed  PubMed Central  Google Scholar 

Rhein J, HupplerHullsiek K, Tugume L, et al. Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial. Lancet Infect Dis. 2019;19:843–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rolfes MA, Rhein J, Schutz C, et al. Cerebrospinal fluid culture positivity and clinical outcomes after amphotericin-based induction therapy for cryptococcal meningitis. Open Forum Infect Dis. 2015;2:ofv157.

Article  PubMed  PubMed Central  Google Scholar 

Chesdachai S, Rajasingham R, Nicol MR, et al. Minimum inhibitory concentration distribution of fluconazole against Cryptococcus species and the fluconazole exposure prediction model. Open Forum Infect Dis. 2019;6(10). https://doi.org/10.1093/ofid/ofz369.

Wake RM, Britz E, Sriruttan C, et al. High cryptococcal antigen titers in blood are predictive of subclinical cryptococcal meningitis among human immunodeficiency virus-infected patients. Clin Infect Dis. 2018;66:686–92.

Article  CAS  PubMed  Google Scholar 

De Schacht C, Smets RM, Callens S, Colebunders R. Bilateral blindness after starting highly active antiretroviral treatment in a patient with HIV infection and cryptococcal meningitis. Acta Clin Belg. 2005;60:10–2.

Article  PubMed  Google Scholar 

Oliveira EP, de Sousa BR, de Freitas JF, et al. Clinical and epidemiological characteristics of neurocryptococcosis associated with HIV in northeastern Brazil. Viruses. 2023;15(5):1206. https://doi.org/10.3390/v15051206.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis. 2006;43:1069–70.

Article  CAS  PubMed  Google Scholar 

Rajasingham R, Wake RM, Beyene T, Katende A, Letang E, Boulware DR. Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing. J Clin Microbiol. 2019;57(1):e01238-18. https://doi.org/10.1128/JCM.01238-18.

Aberg JA, Watson J, Segal M, Chang LW. Clinical utility of monitoring serum cryptococcal antigen (sCRAG) titers in patients with AIDS-related cryptococcal disease. HIV Clin Trials. 2000;1:1–6.

Article  CAS  PubMed  Google Scholar 

Antinori S, Galimberti L, Magni C, et al. Cryptococcus neoformans infection in a cohort of Italian AIDS patients: natural history, early prognostic parameters, and autopsy findings. Eur J Clin Microbiol Infect Dis. 2001;20:711–7.

Article  CAS  PubMed  Google Scholar 

Pullen MF, Kakooza F, Nalintya E, et al. Change in plasma cryptococcal antigen titer is not associated with survival among human immunodeficiency virus-infected persons receiving preemptive therapy for asymptomatic cryptococcal antigenemia. Clin Infect Dis. 2020;70:353–5.

Article  CAS  PubMed  Google Scholar 

Song W, Shen YZ, Wang ZY, et al. Clinical features and treatment outcomes of human immunodeficiency virus-associated cryptococcal meningitis: a 2-year retrospective analysis. Chin Med J (Engl). 2020;133:2787–95.

Article  CAS  PubMed  Google Scholar 

• Bridge S, Hullsiek KH, Nerima C, et al. Evaluation of the BioFire(R) FilmArray(R) meningitis/encephalitis panel in an adult and pediatric Ugandan population. J Mycol Med. 2021;31:101170. Recent study evaluating the BioFire Filmarray panel in cryptococcal meningitis including those with second-episode of cryptococcal meningitis symptoms.

• Rhein J, Bahr NC, Hemmert AC, et al. Diagnostic performance of a multiplex PCR assay for meningitis in an HIV-infected population in Uganda. Diagn Microbiol Infect Dis. 2016;84:268–273. This study provided the first evidence related to the Biofire assay's performance in second episode cryptococcal meningitis.

Van TT, Kim TH, Butler-Wu SM. Evaluation of the BioFire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii. Clin Microbiol Infect. 2020;26:1375–9.

Article  CAS  PubMed  Google Scholar 

Zhang X, Lin Y, Chen H, et al. Diagnostic performance of metagenomic next-generation sequencing in central nervous system cryptococcosis using cerebrospinal fluid. Infect Drug Resist. 2023;16:6175–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

• World Health Organization. Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Available at: https://www.who.int/publications/i/item/9789240052178. Accessed 27 June 2022. Current WHO guidelines for treatment of cryptococcal disease.

• Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Mycoses 2018;61:290–297. Systematic review of fluconazole resistance in Cryptococcus.

Mpoza E, Rhein J, Abassi M. Emerging fluconazole resistance: implications for the management of cryptococcal meningitis. Med Mycol Case Rep. 2018;19:30–2.

Article  PubMed  Google Scholar 

Naicker SD, Mpembe RS, Maphanga TG, et al. Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade. PLoS Negl Trop Dis. 2020;14:e0008137.

Article  PubMed  PubMed Central  Google Scholar 

Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-year analysis of susceptibilities of noncandidal yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol. 2009;47:117–23.

Article  CAS  PubMed  Google Scholar 

Smith KD, Achan B, Hullsiek KH, et al. Increased antifungal drug resistance in clinical isolates of Cryptococcus neoformans in Uganda. Antimicrob Agents Chemother. 2015;59:7197–204.